Your Search Results

Transcatheter solutions in complex valvular or structural scenarios - Part 2

17 May 2022 – From EuroPCR 2022

Consult this session to discover various transcatheter solutions in complex valvular or structural scenarios, such as: percutaneous closure of ascending aorta pseudoaneurysm post-Bentall operation, TEE in mitral transcatheter edge-to-edge repair, and more!

Innovative solutions in complex coronary lesions - Part 1

18 May 2022 – From EuroPCR 2022

Consult this session to discover some innovative solutions in complex coronary lesions, such as: revascularisation for a case with ULMCA and RCA calcification CTO, stentless treatment for left main quadrifurcation lesion, OCT-guided PCI with intravascular lithotripsy in a calcified SVG, and more!

Innovative solutions in complex coronary lesions - Part 2

18 May 2022 – From EuroPCR 2022

Consult this session to learn about innovative solutions in complex coronary lesions, thanks to a variety of cases such as: PCI in a patient with absolute contraindication to contrast administration, another kiss in bifurcation, unexplained hypotension and a new mass, and more!

Innovative solutions in complex coronary lesions - Part 3

18 May 2022 – From EuroPCR 2022

Watch these videos to discover some innovative solutions in complex coronary lesions, thanks to a selection of cases: a 27-year-old woman with STEMI and multiple culprit lesions, an unusual communication between aorta and the heart, CTO RCA done with retrograde approach with reverse CART technique, and more!

Outcomes in patients with atrial fibrillation randomized to receive LAA closure or oral anticoagulation: Primary results of the CHAMPION-AF clinical trial

28 Mar 2026

During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).

Author

Luigi Biasco

CHAMPION-AF: LAAC vs oral anticoagulation in atrial fibrillation

The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement

18 Sep 2022

Jonathan Curio provides his take on the PROTECTED TAVR study which was presented by Samir R. Kapadia at TCT 2022. The aim was to evaluate whether TAVR with cerebral embolic protection would reduce the rate of clinical stroke in transfemoral TAVR.